Eupraxia Pharmaceuticals
Victoria, BC, Canada
Eupraxia co-founder Dr. Malone has worked on the development of drug delivery systems for over 15 years. Dr. Malone has worked on multiple complex extended-release products including: parenteral injections for the treatment and prevention of a wide variety of diseases, intravaginal rings releasing multiple drugs for the prevention of HIV, anti-infective films for the prevention of surgical site infections and topical co-drugs for the treatment of herpes. Dr. Malone has authored 15 publications related to bone function and polymer-based drug delivery, as well as authoring five distinct patent families with patents granted in the US, EU and Oceania. She has been a Principal Investigator on studies awarded more than US$11 million in grant funding from the US and Canadian governments and was a National Science Foundation Fellow.
While at Eupraxia, she has guided the scientific programs through pre-clinical and manufacturing development, the regulatory process in multiple jurisdictions and into the clinic. Before joining Eupraxia, Dr. Malone was the VP and COO of a drug-delivery focused biotech company, Auritec. She graduated with High Honors from Harvey Mudd College in Claremont, California, with a degree in Engineering, received her master’s degree in Mechanical Engineering from Stanford University, and was the inaugural PhD student in Stanford’s Bioengineering Department, where she received a BioX Fellowship.
Tuesday, November 14, 2023
9:00 AM – 11:00 AM PT
Disclosure information not submitted.